Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Current Leases: 2022-2023

Historic Current Leases for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $3.4 million.

  • Therapeutics' Current Leases fell 25.24% to $3.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.4 million, marking a year-over-year decrease of 25.24%. This contributed to the annual value of $4.0 million for FY2022, which is N/A change from last year.
  • As of Q3 2023, Therapeutics' Current Leases stood at $3.4 million, which was up 18.02% from $2.9 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Current Leases registered a high of $5.6 million during Q1 2022, and its lowest value of $2.9 million during Q2 2023.
  • Moreover, its 2-year median value for Current Leases was $4.0 million (2022), whereas its average is $4.1 million.
  • Data for Therapeutics' Current Leases shows a maximum YoY crashed of 44.61% (in 2023) over the last 5 years.
  • Over the past 2 years, Therapeutics' Current Leases (Quarterly) stood at $4.0 million in 2022, then dropped by 25.24% to $3.4 million in 2023.
  • Its Current Leases was $3.4 million in Q3 2023, compared to $2.9 million in Q2 2023 and $3.1 million in Q1 2023.